Involvement of cAMP/Epac/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle

Molecular and Cellular Endocrinology

Volumn 315, Issue 1-2, 2010, Pages 104-112

  Baviera, Amanda Martins ^a   Zanon, Neusa Maria ^b   Navegantes, Luiz Carlos C ^b   Kettelhut, Isis Carmo ^b  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AKT; cAMP; Epac; Foxo3a; PKA; Skeletal muscle proteolysis

Indexed keywords

ADRENALIN; ANTIPORTER; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CYCLIC AMP; INSULIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; EXTENSOR DIGITORUM LONGUS MUSCLE; INHIBITION KINETICS; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BUCLADESINE; CYCLIC AMP; EPINEPHRINE; FORKHEAD TRANSCRIPTION FACTORS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INSULIN; MALE; MUSCLE, SKELETAL; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RIBONUCLEOSIDES; SIGNAL TRANSDUCTION;

EID: 71849084153     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.09.028     Document Type: Article

References (44)

1. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., and Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15 (1996) 6541-6551
2. 2+-dependent and ATP-proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats. Am. J. Physiol. Endocrinol. Metab. 286 (2007) E702-E708
3. Baviera A.M., Zanon N.M., Navegantes L.C., Migliorini R.H., and Kettelhut I.C. Chemical sympathectomy further increases muscle protein degradation of acutely diabetic rats. Muscle Nerve 38 (2008) 1027-1035
4. Blommaart E.F., Krause U., Schellens J.P., Vreeling-Sindelárová H., and Meijer A.J. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 243 (1997) 240-246
5. Borland G., Smith B.O., and Yarwood S.J. EPAC proteins transduce diverse cellular actions of cAMP. Br. J. Pharmacol. 158 (2009) 70-86
6. Brennesvik E.O., Ktori C., Ruzzin J., Jebens E., Shepherd P.R., and Jensen J. Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline. Cell. Signal. 17 (2005) 1551-1559
7. Cheng X., Ji Z., Tsalkova T., and Mei F. Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim. Biophys. Sin. 40 (2008) 651-662
8. Dardevet D., Sornet C., Vary T., and Grizard J. Phosphatidylinositol 3-kinase and p70s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Endocrinology 137 (1996) 4087-4094
9. De Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., and Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
10. Enserink J.M., Christensen A.E., De Rooij J., van Triest M., Schwede F., Genieser H.G., Døskeland S.O., Blank J.L., and Bos J.L. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell. Biol. 4 (2002) 901-906
11. Fang C.H., Li B.G., James J.H., King J.K., Evenson A.R., Warden G.D., and Hasselgren P.O. Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor I and glycogen synthase kinase-3beta inhibitors. Endocrinology 146 (2005) 3141-3149
12. Frost R.A., and Lang C.H. Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J. Appl. Physiol. 103 (2007) 378-387
13. Gonçalves, D.A., Lira, E.C., Baviera, A.M., Cao, P., Zanon, N.M., Arany, Z., Bedard, N., Tanksale, P., Wing, S.S., Lecker, S.H., Kettelhut, I.C., Navegantes, L.C., in press. Mechanisms involved in cAMP-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle. Endocrinology.
14. Jensen J., Grønning-Wang L.M., Jebens E., Whitehead J.P., Zorec R., and Shepherd P.R. Adrenaline potentiates insulin-stimulated PKB activation in the rat fast-twitch epitrochlearis muscle without affecting IRS-1-associated PI 3-kinase activity. Pflugers Arch. 456 (2008) 969-978
15. Kawasaki H., Springett G.M., Mochizuki N., Toki S., Nakaya M., Matsuda M., Housman D.E., and Graybiel A.M. A family of cAMP-binding proteins that directly activate Rap1. Science 282 (1998) 2275-2279
16. Kline W.O., Panaro F.J., Yang H., and Bodine S.C. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J. Appl. Physiol. 102 (2007) 740-747
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
18. 2+-dependent and ubiquitin/proteasome-dependent proteolytic pathways in fast-twitch and slow-twitch rat muscle following hyperinsulinaemia. Clin. Sci. (Lond.) 101 (2001) 551-558
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Lynch G.S., and Ryall J.G. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol. Rev. 88 (2008) 729-767
21. Machida K., Inoue H., Matsumoto K., Tsuda M., Fufuyama S., Koto H., Aizawa H., Kureishi Y., Hara N., and Nakanishi Y. Activation of PI3K-AKT pathway mediates antiapoptotic effects of b-adrenergic agonist in airway eosinophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L860-L867
22. Mei F.C., Qiao J., Tsygankova O.M., Meinkoth J.L., Quilliam L.A., and Cheng X. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J. Biol. Chem. 277 (2002) 11497-11504
23. Mersmann H.J. Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action. J. Anim. Sci. 76 (1998) 160-172
24. Métrich M., Lucas A., Gastineau M., Samuel J.L., Heymes C., Morel E., and Lezoualc'h F. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ. Res. 102 (2008) 959-965
25. Misra U.K., and Pizzo S.V. Coordinate regulation of forskolin-induced cellular proliferation in macrophages by PKA-CREB and Epac1-Rap1 signaling: effects of silencing CREB gene expression on AKT activation. J. Biol. Chem. 280 (2005) 38276-38289
26. Mitch W.E., Bailey J.L., Wang X., Jurkovitz C., Newby D., and Price S.R. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol. 276 (1999) C1132-C1138
27. Nader G.A. Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int. J. Biochem. Cell Biol. 37 (2005) 1985-1996
28. Navegantes L.C., Migliorini R.H., and Kettelhut I.C. Adrenergic control of protein metabolism in skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 5 (2002) 281-286
29. Navegantes L.C., Resano N.M., Baviera A.M., Migliorini R.H., and Kettelhut I.C. Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E642-E647
30. 2+-dependent proteolysis in rat skeletal muscle through beta2-adrenoceptors and cAMP. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E449-E454
31. Navegantes L.C., Resano N.M., Migliorini R.H., and Kettelhut I.C. Effect of guanethidine-induced adrenergic blockade on the different proteolytic systems in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 277 (1999) E883-E889
32. Navegantes L.C., Resano N.M., Migliorini R.H., and Kettelhut I.C. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E663-E668
33. Parr T., Sensky P.L., Arnold M.K., Bardsley R.G., and Buttery P.J. Effects of epinephrine infusion on expression of calpastatin in porcine cardiac and skeletal muscle. Arch. Biochem. Biophys. 374 (2000) 299-305
34. Pepato M.T., Migliorini R.H., Goldberg A.L., and Kettelhut I.C. Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. Am. J. Physiol. Endocrinol. Metab. 271 (1996) E340-E347
35. Roscioni S.S., Elzinga C.R., and Schmidt M. Epac: effectors and biological functions. Naunyn Schmiedebergs Arch. Pharmacol. 377 (2008) 345-357
36. Salem M., Levesque H., Moon T.W., Rexroad C.E., and Yao J. Anabolic effects of feeding beta2-adrenergic agonists on rainbow trout muscle proteases and proteins. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 144 (2006) 145-154
37. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., and Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
38. Sensky P.L., Jewell K.K., Ryan K.J., Parr T., Bardsley R.G., and Buttery P.J. Effect of anabolic agents on calpastatin promoters in porcine skeletal muscle and their responsiveness to cyclic adenosine monophosphate- and calcium-related stimuli. J. Anim. Sci. 84 (2006) 2973-2982
39. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., Gonzalez M., Yancopoulos G.D., and Glass D.J. The IGF-1/PI3K/AKT pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting Foxo transcription factors. Mol. Cell 14 (2004) 395-403
40. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 4350-4354
41. Waalkes T.P., and Udenfriend S. A fluorimetric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. 50 (1957) 733-736
42. Walker K.S., Deak M., Paterson A., Hudson K., Cohen P., and Alessi D.R. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem. J. 331 (1998) 299-308
43. Wang X., Hu Z., Hu J., Du J., and Mitch W.E. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147 (2006) 4160-4168
44. Yimlamai T., Dodd S.L., Borst S.E., and Park S. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. J. Appl. Physiol. 99 (2005) 71-80